12:00 AM
 | 
Feb 25, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

HER2 IQFISH pharmDx test regulatory update

Agilent's Dako A/S company said FDA approved the HER2 IQFISH pharmDx test as an aid in the assessment of patients for whom

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >